Fulcrum Therapeutics Q1 2026 Earnings Narrowed Loss Exceeds Analyst Expectations NMRA Q1 2026 Earnings NarrowerthanExpected Loss Reflects Operational Discipline ADAML Q1 2026 Earnings Significant EPS Beat as Preferred Stock Delivers Strong Performance ADCT Q1 2026 Earnings Narrowed Loss Beats Estimates Stock Surges American Shared Hospital Services Q1 2026 Earnings Significant EPS Miss as Losses Deepen VIPS Q1 2026 Earnings EPS Misses Estimates Shares Dip